key unmet needs in t-cell lymphoma: developing novel therapeutic strategies to improve outcomes
Published 1 year ago • 60 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
2:32
unmet needs in t-cell lymphoma and the importance of better understanding disease biology
-
1:34
unmet needs in t-cell lymphoma
-
1:52
unmet needs in the treatment of t-cell malignancies
-
7:52
highlights in t-cell lymphoma: unmet needs, clinical trial updates, and future outlooks
-
1:13
the unmet needs and future of cmml treatment
-
1:27
unmet needs and future questions in cellular therapy for myeloma
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
2:59
clinical trials and novel agents under investigation in t-cell lymphoma
-
3:02
immune system - natural killer cell
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
2:50
cutaneous t-cell lymphoma - yale medicine explains
-
1:58
an overview on nk/t-cell lymphoma treatment
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:57
key trials in ctcl
-
3:31
upcoming trials and agents in t-cell lymphoma
-
1:15
hello tellomak: new trial for t-cell lymphoma
-
6:14
horizon scan of car-t for lymphoma
-
6:28
outcomes following first-line therapy in routine clinical practice in alcl
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
5:24
treatment strategies for patients with dlbcl who relapse after car-t therapy
-
0:42
targeted therapies for dlbcl treatment